CU23436B6 - Método para tratar inflamaciones del colon, recto, canal anal o región perianal - Google Patents
Método para tratar inflamaciones del colon, recto, canal anal o región perianalInfo
- Publication number
- CU23436B6 CU23436B6 CU20050039A CU20050039A CU23436B6 CU 23436 B6 CU23436 B6 CU 23436B6 CU 20050039 A CU20050039 A CU 20050039A CU 20050039 A CU20050039 A CU 20050039A CU 23436 B6 CU23436 B6 CU 23436B6
- Authority
- CU
- Cuba
- Prior art keywords
- inflamations
- colon
- treat
- straight
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Método para tratar las inflamaciones del colon, recto, canal anal o región perianal. La composición tópica puede ser utilizada en el tratamiento de las condiciones del colon, recto, anorrecto y de la región perianal, en particular la enfermedad inflamatoria del intestino y la enfermedad de Crohn perianal. La composición también alivia el dolor y la inflamación y promueve el sanado del colon, recto, anorecto y de la región perianal después de operaciones quirúrgicas. Una ventaja de la composición es que la administración tópica del metronidazol conduce a un efecto principalmente local y por consiguiente los efectos secundarios observados de la administración sistémica son evitados.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40635102P | 2002-08-26 | 2002-08-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
CU23436B6 true CU23436B6 (es) | 2009-10-16 |
Family
ID=31946965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20050039A CU23436B6 (es) | 2002-08-26 | 2005-02-24 | Método para tratar inflamaciones del colon, recto, canal anal o región perianal |
Country Status (29)
Country | Link |
---|---|
US (5) | US20060240123A1 (es) |
EP (1) | EP1545516B1 (es) |
KR (1) | KR100991054B1 (es) |
CN (2) | CN101843614B (es) |
AT (1) | ATE406890T1 (es) |
AU (1) | AU2003260736B8 (es) |
BR (1) | BR0313824A (es) |
CA (1) | CA2496864C (es) |
CR (1) | CR7768A (es) |
CU (1) | CU23436B6 (es) |
CY (1) | CY1108601T1 (es) |
DE (1) | DE60323380D1 (es) |
DK (1) | DK1545516T3 (es) |
EA (1) | EA008150B1 (es) |
ES (1) | ES2312847T3 (es) |
HK (1) | HK1077758A1 (es) |
HR (1) | HRP20050258A2 (es) |
IL (1) | IL167069A (es) |
IS (1) | IS7761A (es) |
MA (1) | MA27520A1 (es) |
MX (1) | MXPA05002033A (es) |
NO (1) | NO333670B1 (es) |
NZ (1) | NZ538998A (es) |
PL (1) | PL375560A1 (es) |
PT (1) | PT1545516E (es) |
RS (1) | RS20050170A (es) |
UA (1) | UA81638C2 (es) |
WO (1) | WO2004017962A2 (es) |
ZA (1) | ZA200502365B (es) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
EP1556009B2 (en) | 2002-10-25 | 2021-07-21 | Foamix Pharmaceuticals Ltd. | Cosmetic and pharmaceutical foam |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US7928132B2 (en) * | 2004-08-06 | 2011-04-19 | Ohio University | Methods for the amelioration of episodes of acute or chronic ulcerative colitis |
JP2007529510A (ja) * | 2004-03-16 | 2007-10-25 | インターシア・コーポレイション | 細胞接着を抑制するメチマゾール誘導体及び互変異性環状チオン |
US20060211752A1 (en) | 2004-03-16 | 2006-09-21 | Kohn Leonard D | Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression |
ITMI20041295A1 (it) * | 2004-06-25 | 2004-09-25 | Cosmo Spa | Composizioni farmaceutiche antimicrobiche orali |
CN1291754C (zh) * | 2005-07-12 | 2006-12-27 | 李赴朝 | 局麻药增效延时剂 |
FR2899475A1 (fr) * | 2006-04-10 | 2007-10-12 | Galderma Res & Dev | Composition pharmaceutique pour le traitement de la rosacee |
CN100421648C (zh) * | 2006-08-15 | 2008-10-01 | 苏州市立医院 | 氢化考的松灌肠剂及其制备方法 |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
AU2009205314A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
WO2009137672A1 (en) * | 2008-05-07 | 2009-11-12 | Salix Pharmaceuticals, Ltd. | Methods of treating bowel disease by administering a bowel cleanser and an antibiotic |
WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
AU2010302350B2 (en) | 2009-10-02 | 2015-06-18 | Journey Medical Corporation | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
IT1396731B1 (it) * | 2009-11-25 | 2012-12-14 | Masci | Composizione farmaceutica a base di metronidazolo ed ossido di zinco per il trattamento topico di patologie anali acute e croniche distrofiche e post-operatorie |
US20120177582A1 (en) * | 2011-01-11 | 2012-07-12 | Ramirez Jose E | Compositions for anorectal use and methods for treating anorectal disorders |
US8952057B2 (en) * | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
WO2013012662A2 (en) * | 2011-07-15 | 2013-01-24 | S.L.A. Pharma Ag | Pharmaceutical compositions for rectal administration |
CN102920665B (zh) * | 2012-12-04 | 2014-06-11 | 四川省川龙动科药业有限公司 | 结肠靶向氧化锌微丸及其制备方法 |
US9750723B2 (en) | 2013-10-31 | 2017-09-05 | Ohio University | Prevention and treatment of non-alcoholic fatty liver disease |
CN106659746A (zh) * | 2014-04-10 | 2017-05-10 | 国立研究开发法人理化学研究所 | 用于诱导th17细胞的组合物及方法 |
RU2605615C2 (ru) * | 2014-07-15 | 2016-12-27 | Общество с ограниченной ответственностью "Гелизовит" | Ректальный поликомплексный гель для лечения язвенного колита, болезни крона, свищей и осложнений, вызванных этими заболеваниями |
US10023567B2 (en) | 2014-07-18 | 2018-07-17 | Ohio University | Imidazole and thiazole compositions for modifying biological signaling |
US10588864B2 (en) | 2016-03-11 | 2020-03-17 | Gateway Pharmaceuticals LLC | Pharmaceutical compositions for colon-specific delivery |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
US20190175558A1 (en) * | 2017-12-07 | 2019-06-13 | S.L.A. Pharma Ag | Topical pharmaceutical compositions for treatment of tissue damage |
US20210322458A1 (en) * | 2020-04-20 | 2021-10-21 | Gregg Tobin | Methods and compositions for treatment of burns, joint pain, and fungal infections |
WO2022123305A1 (en) * | 2020-12-07 | 2022-06-16 | S.L.A. Pharma Ag | Compositions comprising metronidazole for treatment of diabetic foot ulcers and venous ulcers |
US11951082B2 (en) * | 2022-08-22 | 2024-04-09 | Ford Therapeutics, Llc | Composition of chlorhexidine |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3620674A1 (de) * | 1986-06-20 | 1987-12-23 | Nattermann A & Cie | Salbe zur behandlung von hauterkrankungen |
US4957918A (en) * | 1988-06-09 | 1990-09-18 | Leonard Bloom | Topical treatment of blepharitis |
CA2011423A1 (en) * | 1989-03-07 | 1990-09-07 | Peter M. Taylor | Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings |
US5143934A (en) | 1990-11-21 | 1992-09-01 | A/S Dumex (Dumex Ltd.) | Method and composition for controlled delivery of biologically active agents |
NZ235876A (en) * | 1989-11-01 | 1992-06-25 | Mcneil Ppc Inc | Pharmaceutical compositions containing effective amount of antidiarrheal composition and antiflatulent effective amount of simethicone |
RU2128040C1 (ru) | 1996-03-19 | 1999-03-27 | Николай Васильевич Дмитриенко | Линимент "фузол" лекарственного препарата, обладающего противовоспалительным, ранозаживляющим и регенеративным действием, и способ его получения |
CN1202358A (zh) * | 1997-06-12 | 1998-12-23 | 马秀珍 | 治疗痤疮毛囊炎湿疹的水剂、膏剂 |
US5948400A (en) * | 1997-11-20 | 1999-09-07 | Smith & Nephew Inc. | Method of applying a pressure-sensitive adhesive wound dressing and water-based skin treatment composition |
KR100671879B1 (ko) * | 1999-07-16 | 2007-01-19 | 가부시키가이샤 쇼에이 | 니트로이미다졸 함유 피부 질환용 외용제 |
CN1291484A (zh) | 2000-08-18 | 2001-04-18 | 周文山 | 一种治疗***的药物 |
UA53946A (uk) | 2002-03-25 | 2003-02-17 | Донецький Державний Медичний Університет Ім. М. Горького | Склад для лікування генералізованого пародонтиту у віл-інфікованих |
UA53946U (ru) | 2010-04-12 | 2010-10-25 | Тернопольский Национальный Технический Университет Имени Ивана Пулюя | Способ получения модифицированного эпоксикомпозитного покрытия |
-
2003
- 2003-08-22 US US10/525,208 patent/US20060240123A1/en not_active Abandoned
- 2003-08-22 DK DK03792521T patent/DK1545516T3/da active
- 2003-08-22 DE DE60323380T patent/DE60323380D1/de not_active Expired - Lifetime
- 2003-08-22 KR KR1020057003310A patent/KR100991054B1/ko not_active IP Right Cessation
- 2003-08-22 EA EA200500401A patent/EA008150B1/ru unknown
- 2003-08-22 CA CA002496864A patent/CA2496864C/en not_active Expired - Lifetime
- 2003-08-22 AT AT03792521T patent/ATE406890T1/de active
- 2003-08-22 NZ NZ538998A patent/NZ538998A/en not_active IP Right Cessation
- 2003-08-22 RS YUP-2005/0170A patent/RS20050170A/sr unknown
- 2003-08-22 WO PCT/GB2003/003692 patent/WO2004017962A2/en active IP Right Grant
- 2003-08-22 BR BR0313824-0A patent/BR0313824A/pt not_active Application Discontinuation
- 2003-08-22 CN CN2010101145599A patent/CN101843614B/zh not_active Expired - Fee Related
- 2003-08-22 MX MXPA05002033A patent/MXPA05002033A/es active IP Right Grant
- 2003-08-22 PT PT03792521T patent/PT1545516E/pt unknown
- 2003-08-22 EP EP03792521A patent/EP1545516B1/en not_active Expired - Lifetime
- 2003-08-22 UA UAA200502616A patent/UA81638C2/ru unknown
- 2003-08-22 AU AU2003260736A patent/AU2003260736B8/en not_active Expired
- 2003-08-22 PL PL03375560A patent/PL375560A1/xx not_active Application Discontinuation
- 2003-08-22 CN CNA038201747A patent/CN1678309A/zh active Pending
- 2003-08-22 ES ES03792521T patent/ES2312847T3/es not_active Expired - Lifetime
-
2005
- 2005-02-23 IL IL167069A patent/IL167069A/en active IP Right Grant
- 2005-02-24 CU CU20050039A patent/CU23436B6/es not_active IP Right Cessation
- 2005-03-18 HR HR20050258A patent/HRP20050258A2/hr not_active Application Discontinuation
- 2005-03-21 IS IS7761A patent/IS7761A/is unknown
- 2005-03-21 MA MA28167A patent/MA27520A1/fr unknown
- 2005-03-22 ZA ZA200502365A patent/ZA200502365B/en unknown
- 2005-03-23 NO NO20051542A patent/NO333670B1/no not_active IP Right Cessation
- 2005-03-28 CR CR7768A patent/CR7768A/es not_active Application Discontinuation
- 2005-12-16 HK HK05111623A patent/HK1077758A1/xx not_active IP Right Cessation
-
2008
- 2008-11-26 CY CY20081101369T patent/CY1108601T1/el unknown
-
2010
- 2010-07-12 US US12/834,198 patent/US9655883B2/en active Active
-
2013
- 2013-03-15 US US13/834,281 patent/US10653671B2/en not_active Expired - Fee Related
-
2014
- 2014-05-28 US US14/288,686 patent/US10709689B2/en not_active Expired - Fee Related
-
2016
- 2016-08-11 US US15/234,084 patent/US10881640B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU23436B6 (es) | Método para tratar inflamaciones del colon, recto, canal anal o región perianal | |
PT1296650E (pt) | Metodos e composicoes para tratamento de dor da membrana mucosa | |
DK1363600T3 (da) | Flydende formuleringer til forebyggelse og behandling af mucosale sygdomme og lidelser | |
TR200103474T2 (tr) | Bileşimlerin anti-bakteriyel madde olarak yeni kullanımları | |
ECSP055844A (es) | Nuevos compuestos triciclicos | |
NO20031648D0 (no) | Farmasöytiske lösninger av modafinilforbindelser | |
BR0206568A (pt) | Novo método e composições para o tratamento local de doença de meniere, de zumbido no ouvido e/ou de perda de audição | |
ATE445389T1 (de) | Liposomale glucocorticoide | |
DK1397105T3 (da) | Præparat til inhibering af angiogenese | |
BR9911060A (pt) | Composições compreendendo mono- ou dinitrato orgânico para tratar impotência | |
EE200200636A (et) | Dibensoasuleeni derivaadid, nende valmistamismeetodid ja kasutamine | |
SE9802794D0 (sv) | New compounds | |
TR200002248T2 (tr) | Yeni dihidroksiheksanoik asit türevleri | |
SE9802793D0 (sv) | New compounds | |
ATE253369T1 (de) | Phosphatidylcholin als arzneimittel mit schleimhautschützender wirkung | |
TW200503675A (en) | Combination of phenylcarboxamides with blockers of the Ikr channel and their use for the treatment of atrial arrhythmias | |
FI20002525A0 (fi) | Tulehduksenvastaisia aineita | |
EA201100575A1 (ru) | Композиция дигидрата 3-(2,2,2-триметилгидразиниум)пропионата для наружного местного применения | |
BR0307342A (pt) | Terapia de combinação de antagonista aldosterona e agente antiiflamatório não-esteróide para prevenir ou tratar distúrbios cardiovasculares | |
TR200103238T2 (tr) | Cis-[4-Siano-4-(3-siklopentiloksi-4-metoksifenil) sikloheksan-1-karboksilat] tuzları | |
TR200605520T2 (tr) | Saç kaybı ve iyi huylu prostatik hiperplazinin tedavisine yönelik farmasötik bileşim | |
CY1118235T1 (el) | Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ii | |
CY1107334T1 (el) | Μεθοδοι για την αναστολη της αγγειογενεσης | |
AR031146A1 (es) | Una composicion estable para el tratamiento topico de ulceras de la piel del tipo que corresponde a un gel o masa mucilaginosa y procedimiento para su preparacion | |
HN2002000106A (es) | Piper nigrum como agente antiinflamatorio en compuestos orales y dermatologicos. (pimienta negra). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Lapse (for not paying fees) |